Michael Parsons is a Ph. D. scientist at Vertex Pharmaceuticals with over 20 years of experience developing in vitro genetic models of disease. His expertise lies in using methodologies like CRISPR to create functional assays for small molecule screens, focusing on muscle and kidney diseases.
He earned his Ph. D. from the University of Wisconsin-Madison and the Institute of Psychiatry, Kings College London.
His research identified a specific gene mutation (Zfhx3) that accelerates circadian locomotor rhythms, a key finding in the genetics of sleep.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.